Agilon Health (NYSE:AGL) Trading 12.6% Higher – What’s Next?

Agilon Health, Inc. (NYSE:AGL) traded up 12.6% during trading on Thursday . The stock traded as high as $93.79 and last traded at $93.1160. 49,253 shares changed hands during trading, a decline of 86% from the average session volume of 357,793 shares. The stock had previously closed at $82.70.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the stock. Jefferies Financial Group upgraded shares of Agilon Health from a “hold” rating to a “buy” rating and boosted their target price for the stock from $27.50 to $48.00 in a research report on Thursday, May 7th. Weiss Ratings lowered shares of Agilon Health from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, May 27th. JPMorgan Chase & Co. lowered shares of Agilon Health from a “neutral” rating to an “underweight” rating and set a $21.00 price objective on the stock. in a research report on Monday, May 4th. Barclays upgraded shares of Agilon Health from an “underweight” rating to an “equal weight” rating and set a $81.00 price objective on the stock in a research report on Tuesday, May 26th. Finally, Wells Fargo & Company reiterated an “overweight” rating and issued a $72.00 price objective (up from $37.50) on shares of Agilon Health in a research report on Friday, May 8th. Five investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have given a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $58.73.

Agilon Health Stock Up 1.2%

The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.04 and a current ratio of 1.04. The firm’s 50-day moving average is $47.53 and its 200 day moving average is $27.47. The firm has a market capitalization of $1.61 billion, a PE ratio of -4.47 and a beta of 3.02.

Agilon Health (NYSE:AGL) last released its quarterly earnings data on Wednesday, May 6th. The company reported $1.80 EPS for the quarter, topping the consensus estimate of $1.04 by $0.76. Agilon Health had a negative net margin of 6.09% and a negative return on equity of 146.03%. The business had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.38 billion. As a group, research analysts forecast that Agilon Health, Inc. will post -3.5 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. CenterBook Partners LP raised its stake in Agilon Health by 492.4% in the 3rd quarter. CenterBook Partners LP now owns 11,428,027 shares of the company’s stock valued at $11,771,000 after purchasing an additional 9,499,012 shares during the last quarter. State of Wyoming raised its stake in Agilon Health by 29.5% in the 3rd quarter. State of Wyoming now owns 218,092 shares of the company’s stock valued at $225,000 after purchasing an additional 49,631 shares during the last quarter. Independent Advisor Alliance acquired a new position in Agilon Health in the 3rd quarter valued at about $39,000. Y Intercept Hong Kong Ltd acquired a new position in Agilon Health in the 3rd quarter valued at about $90,000. Finally, Krilogy Financial LLC acquired a new position in Agilon Health in the 4th quarter valued at about $34,000.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.